The San Francisco Travel Association forecast in August that city tourism would rise only modestly through the end of 2025 ...

The South Carolina News Editor is Evan Berland. The breaking news staffer is Skip Foreman. The Columbia bureau can be reached at 800-922-1565. For technical support, please call the AP's ...

AngioDynamics stock is undervalued, with Med Tech growth in thrombus management and atherectomy. Learn more about the company ...

2025, A Year of Momentum: Advancing Toward a Potential Breakthrough in Ovarian Cancer Treatment ...

Following a feud with activist investor Deep Track Capital in the first half of 2025, vaccine developer Dynavax Technologies ...

Stronger triceps means stronger, more toned arms. Try these research-backed exercises to build strength, power, and definition.

If you have $2,000 to invest, here are three top robotics stocks riding the industry's growth wave that you might want to ...

The world of prediction markets hit two significant milestones in late 2024 as major platforms ramped up efforts to establish ...

Green Bay Packers quarterback Malik Willis has delivered on many occasions for the offense. Packers fans weigh in on his ...

No time to get to the gym? Prefer to work out at home? You can build impressive shoulders and muscular arms with this ...

Lexaria says its oral GLP-1 cut total adverse events nearly 48% versus Novo's Rybelsus, with comparable HbA1c results in a Phase 1b study.

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...